Testim and prostate cancer Patient Reports February 09, 2010

Testim Side Effects Report #5350703-X
Testim side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Male patient, 61 years of age, weighting 185.0 lb, was diagnosed with libido disorder and was treated with Testim. After drug was administered, patient experienced the following side effects: prostate cancer . Testim dosage: unknown. Patient recovered.

Testim Side Effects Report #4835154-6
Testim side effect was reported by a Physician from UNITED STATES on Oct 28, 2005. Male patient, 67 years of age, was diagnosed with hypogonadism and was treated with Testim. After drug was administered, patient experienced the following side effects: prostate cancer . Testim dosage: 50 MG, DAILY, TRANSDERMAL. During the same period patient was treated with ALEVE, SEPTRA. Patient recovered.

Testim Side Effects Report #5372457-3
Testim side effect was reported by a Physician from UNITED STATES on June 11, 2007. Male patient, 64 years of age, weighting 176.0 lb, was diagnosed with hypogonadism and was treated with Testim. After drug was administered, patient experienced the following side effects: prostate cancer . Testim dosage: 50 MG, DAILY, TRANSDERMAL. During the same period patient was treated with LEVOXYL. Patient recovered.

Testim Side Effects Report #4815362-0
Testim side effect was reported by a Physician from UNITED STATES on Oct 14, 2005. Male patient, 50 years of age, was diagnosed with blood testosterone decreased and was treated with Testim. After drug was administered, patient experienced the following side effects: erectile dysfunction , prostate cancer . Testim dosage: unknown. Patient recovered.


Testim Side Effects Report #5989509-7
Testim side effect was reported by a Physician from UNITED STATES on Nov 21, 2008. Male patient, 55 years of age, was treated with Testim. After drug was administered, patient experienced the following side effects: prostate cancer . Testim dosage: unknown. Patient recovered.